introduction 3DVH utilizes the Planned Dose Perturbation (PDP) algorithm to accurately estimate dose-to-patient and patient DVH using conventional planar IMRT QA data as inputs. The goal is to produce clinically-relevant metrics to replace conventional metrics that are limited in both sensitivity and specificity. 1, 2 The presence of significant tissue heterogeneities and their effect on PDP accuracy is a consideration given that: input dose planes are a single depth in a homogeneous QA phantom, and CT image sets are not required for the PDP calculation. It is the intent of this technical note to clarify how PDP is very accurate for patient volumes that have significant tissue heterogeneity.
Remapping of CT-based tissue-heterogeneities is not required for 3DVH because 3D dose voxel modification can be accomplished with great accuracy by knowing the patient geometry (surface, internal regions-of-interest), and the beam geometries relative to the patient model. Depthdependence is built into PDP (in addition to other variables, such as the effects of beam energy, linac, and MLC model).
The goal of PDP is not to correct for heterogeneities if the TPS has not, because a properly commissioned modern TPS dose algorithm will account for this.
7 TPS errors (e.g.
beam modeling, failure in a specific patient plan, etc.) or delivery errors (e.g. MLC errors, file corruption, output errors, etc.) that are measured in conventional IMRT QA, are used by PDP to estimate the impact to the patient dose/DVH. The inherent heterogeneity corrections by the TPS will be preserved and the dose voxels will be modified correctly.
Any and all QA systems should be verified with rigor 8 over many permutations of plans and patient types. Accuracy testing of PDP has been discussed 9 , however the focus of this technical note is to illustrate the high performance level of PDP in the presence of large tissue heterogeneities.
materials and methods

Lung IMRT Plan
In order to analyze PDP's accuracy in predicting IMRT dose in the presence of tissue heterogeneities, a previously described method 8 that allows analysis of full density 3D grids is employed; with an emphasis on the large tissue heterogeneities of a lung IMRT plan ( Figure 1 ). An "error- What's the difference?
Single Beam on Heterogeneous Phantom PDP is performed, and the resulting PDP-corrected patient dose/DVH can then be compared to the error-free patient dose/DVH, which was calculated by the error-free beams.
These comparisons quantify the ability of PDP to predict the correct dose in the presence of heterogeneities using patient dose differences and DVH differences as In Figure 4 and 6, the PDP dose resembles the error-free dose even though there were considerable volumes of low-density lung in this patient. Furthermore, if PDP is to be used to compare vs. the original treatment plan, PDP would yield similar comparisons to the original (errorinduced) dose as the true (error-free) dose would. Figure 5 shows that this is true, as the comparison matching rates are 78.7% and 80.5% for the PDP vs. Error-induced and the Error-free vs. Error-induced, respectively*.
Finally, because the patient DVH curves are the common plan evaluation method, the expectation is that the PDP DVHs will be very similar to the actual (error-free) DVHs. In this figure, the PDP-modeled B1 dose (calculating by perturbing the 3D B2 dose using the PDP algorithm)
generates almost identical comparisons to B2 as does the actual B1 dose compared to B2. Furthermore, the PDPmodeled B1 dose matches the actual B1 dose with a 100.0% matching rate at 2%/2mm, absolute dose, using 10% lower dose threshold. This PDP estimation was achieved in a phantom that had a 10 cm thick volume of low density material (0.30 density, relative to water). 
